vs
Ernexa Therapeutics Inc.（ERNA）与Rani Therapeutics Holdings, Inc.（RANI）财务数据对比。点击上方公司名可切换其他公司
Ernexa Therapeutics Inc.是一家总部位于美国的临床阶段生物技术企业，专注于开发针对存在高度未满足医疗需求的罕见神经内分泌、代谢类疾病的新型靶向疗法，致力于为缺乏有效治疗方案的患者群体提供新选择。
Rani Therapeutics Holdings是一家临床阶段生物技术企业，专注于开发可替代注射类生物制剂的口服给药方案，核心专利技术RaniPill是一款机器人给药胶囊，可将大分子药物直接递送至肠壁，免除患者注射痛苦，针对糖尿病、自身免疫疾病、骨质疏松等慢性病患者，与多家头部药企合作推进产品管线。
ERNA vs RANI — 直观对比
营收规模更大
ERNA
是对方的Infinity倍
$0
损益表 — Q4 FY2024 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0K | $0 |
| 净利润 | — | $-5.4M |
| 毛利率 | 100.0% | — |
| 营业利润率 | — | — |
| 净利率 | — | — |
| 营收同比 | — | — |
| 净利润同比 | 6.4% | 20.2% |
| 每股收益（稀释后） | — | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ERNARANI
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $172.0K | ||
| Q4 24 | $1.0K | — | ||
| Q3 24 | $487.0K | $0 | ||
| Q2 24 | $47.0K | $0 | ||
| Q1 24 | $47.0K | $0 | ||
| Q3 23 | $51.0K | — |
净利润ERNARANI
| Q3 25 | — | $-5.4M | ||
| Q2 25 | — | $-6.7M | ||
| Q1 25 | — | $-7.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.6M | $-6.8M | ||
| Q2 24 | $-5.5M | $-6.8M | ||
| Q1 24 | $-6.6M | $-7.5M | ||
| Q3 23 | $-5.6M | — |
毛利率ERNARANI
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 100.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — |
营业利润率ERNARANI
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6984.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -463.9% | — | ||
| Q2 24 | -10491.5% | — | ||
| Q1 24 | -12312.8% | — | ||
| Q3 23 | -10794.1% | — |
净利率ERNARANI
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4223.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -5462.8% | — | ||
| Q2 24 | -11763.8% | — | ||
| Q1 24 | -14142.6% | — | ||
| Q3 23 | -10962.7% | — |
每股收益（稀释后）ERNARANI
| Q3 25 | — | $-0.12 | ||
| Q2 25 | — | $-0.18 | ||
| Q1 25 | — | $-0.22 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-73.70 | $-0.24 | ||
| Q2 24 | $-15.34 | $-0.26 | ||
| Q1 24 | $-1.23 | $-0.29 | ||
| Q3 23 | $-1.03 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7M | $4.1M |
| 总债务越低越好 | — | $13.8M |
| 股东权益账面价值 | $1.7M | $-7.9M |
| 总资产 | $5.3M | $10.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ERNARANI
| Q3 25 | — | $4.1M | ||
| Q2 25 | — | $10.2M | ||
| Q1 25 | — | $10.1M | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $4.3M | $4.3M | ||
| Q2 24 | $2.6M | $4.5M | ||
| Q1 24 | $5.1M | $6.9M | ||
| Q3 23 | $4.6M | — |
总债务ERNARANI
| Q3 25 | — | $13.8M | ||
| Q2 25 | — | $17.5M | ||
| Q1 25 | — | $21.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $28.8M | ||
| Q2 24 | — | $30.0M | ||
| Q1 24 | — | $30.0M | ||
| Q3 23 | — | — |
股东权益ERNARANI
| Q3 25 | — | $-7.9M | ||
| Q2 25 | — | $-5.6M | ||
| Q1 25 | — | $-3.1M | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $-45.4M | $3.1M | ||
| Q2 24 | $-8.5M | $2.8M | ||
| Q1 24 | $-3.4M | $7.4M | ||
| Q3 23 | $3.6M | — |
总资产ERNARANI
| Q3 25 | — | $10.1M | ||
| Q2 25 | — | $16.9M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | $5.3M | — | ||
| Q3 24 | $7.7M | $43.5M | ||
| Q2 24 | $46.5M | $43.7M | ||
| Q1 24 | $49.7M | $53.5M | ||
| Q3 23 | $52.2M | — |
负债/权益比ERNARANI
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 9.21× | ||
| Q2 24 | — | 10.58× | ||
| Q1 24 | — | 4.06× | ||
| Q3 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.8M | $-5.1M |
| 自由现金流经营现金流 - 资本支出 | $-16.2M | — |
| 自由现金流率自由现金流/营收 | -1620500.0% | — |
| 资本支出强度资本支出/营收 | 36900.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-28.9M | — |
8季度趋势，按日历期对齐
经营现金流ERNARANI
| Q3 25 | — | $-5.1M | ||
| Q2 25 | — | $-5.8M | ||
| Q1 25 | — | $-8.1M | ||
| Q4 24 | $-15.8M | — | ||
| Q3 24 | $-6.3M | $-8.4M | ||
| Q2 24 | $-2.3M | $-9.0M | ||
| Q1 24 | $-3.7M | $-9.4M | ||
| Q3 23 | $-5.8M | — |
自由现金流ERNARANI
| Q3 25 | — | — | ||
| Q2 25 | — | $-5.8M | ||
| Q1 25 | — | $-8.2M | ||
| Q4 24 | $-16.2M | — | ||
| Q3 24 | $-6.3M | $-8.5M | ||
| Q2 24 | $-2.5M | $-9.1M | ||
| Q1 24 | $-3.8M | $-9.4M | ||
| Q3 23 | — | — |
自由现金流率ERNARANI
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4767.4% | ||
| Q4 24 | -1620500.0% | — | ||
| Q3 24 | -1294.5% | — | ||
| Q2 24 | -5336.2% | — | ||
| Q1 24 | -8187.2% | — | ||
| Q3 23 | — | — |
资本支出强度ERNARANI
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 29.7% | ||
| Q4 24 | 36900.0% | — | ||
| Q3 24 | 3.9% | — | ||
| Q2 24 | 529.8% | — | ||
| Q1 24 | 214.9% | — | ||
| Q3 23 | 0.0% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
